These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16801412)

  • 1. In vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance.
    McCallum N; Karauzum H; Getzmann R; Bischoff M; Majcherczyk P; Berger-Bächi B; Landmann R
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2352-60. PubMed ID: 16801412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in a glycopeptide-susceptible, methicillin-resistant strain of Staphylococcus aureus.
    Vaudaux P; Francois P; Berger-Bächi B; Lew DP
    J Antimicrob Chemother; 2001 Feb; 47(2):163-70. PubMed ID: 11157900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased uptake and improved intracellular survival of a teicoplanin-resistant mutant of methicillin-resistant Staphylococcus aureus in non-professional phagocytes.
    Renzoni A; Huggler E; Kelley WL; Lew D; Vaudaux P
    Chemotherapy; 2009; 55(3):183-8. PubMed ID: 19407446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of fibronectin adhesins and other virulence factors in a teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.
    Renzoni A; Francois P; Li D; Kelley WL; Lew DP; Vaudaux P; Schrenzel J
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2958-65. PubMed ID: 15273106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Glycopeptide Resistance in Staphylococcus aureus on the Dalbavancin In Vivo Pharmacodynamic Target.
    Lepak A; Marchillo K; VanHecker J; Andes D
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7833-6. PubMed ID: 26392492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of TcaA: minimal requirement for teicoplanin susceptibility and role in Caenorhabditis elegans virulence.
    McCallum N; Brassinga AK; Sifri CD; Berger-Bächi B
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3836-43. PubMed ID: 17709474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. tcaA inactivation increases glycopeptide resistance in Staphylococcus aureus.
    Maki H; McCallum N; Bischoff M; Wada A; Berger-Bächi B
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1953-9. PubMed ID: 15155184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of glycopeptide resistance in a highly teicoplanin-resistant mutant of Staphylococcus aureus by transposon inactivation of genes involved in cell wall synthesis.
    Sieradzki K; Tomasz A
    Microb Drug Resist; 1998; 4(3):159-68. PubMed ID: 9818967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to teicoplanin developing during treatment of methicillin-resistant Staphylococcus aureus infection.
    Elsaghier AA; Aucken HM; Hamilton-Miller JM; Shaw S; Kibbler CC
    J Antimicrob Chemother; 2002 Feb; 49(2):423-4. PubMed ID: 11815594
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus.
    Tascini C; Flammini S; Leonildi A; Ciullo I; Tagliaferri E; Menichetti F
    J Chemother; 2012 Aug; 24(4):187-90. PubMed ID: 23040680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification by genomic and genetic analysis of two new genes playing a key role in intermediate glycopeptide resistance in Staphylococcus aureus.
    Renzoni A; Kelley WL; Barras C; Monod A; Huggler E; François P; Schrenzel J; Studer R; Vaudaux P; Lew DP
    Antimicrob Agents Chemother; 2009 Mar; 53(3):903-11. PubMed ID: 19104009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of multiple genetic loci in Staphylococcus aureus teicoplanin resistance.
    Bischoff M; Roos M; Putnik J; Wada A; Glanzmann P; Giachino P; Vaudaux P; Berger-Bächi B
    FEMS Microbiol Lett; 2001 Jan; 194(1):77-82. PubMed ID: 11150669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teicoplanin pharmacodynamics in reference to the accessory gene regulator (agr) in Staphylococcus aureus using an in vitro pharmacodynamic model.
    Rose WE; Kaatz GW; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2008 May; 61(5):1099-102. PubMed ID: 18263568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of resistance mechanisms and biological characteristics of rifampicin-resistant Staphylococcus aureus strains selected in vitro.
    Wang C; Fang R; Zhou B; Tian X; Zhang X; Zheng X; Zhang S; Dong G; Cao J; Zhou T
    BMC Microbiol; 2019 Sep; 19(1):220. PubMed ID: 31533633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus.
    Cui L; Lian JQ; Neoh HM; Reyes E; Hiramatsu K
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3404-13. PubMed ID: 16048954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital.
    Nakipoglu Y; Derbentli S; Cagatay AA; Katranci H
    BMC Infect Dis; 2005 May; 5():31. PubMed ID: 15871748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teicoplanin resistance in methicillin-resistant Staphylococcus aureus in an intensive care unit.
    Cepeda J; Hayman S; Whitehouse T; Kibbler CC; Livermore D; Singer M; Wilson AP
    J Antimicrob Chemother; 2003 Sep; 52(3):533-4. PubMed ID: 12888581
    [No Abstract]   [Full Text] [Related]  

  • 18. Concentration dependent exposure of vancomycin and teicoplanin induces vanG regulon in Staphylococcus aureus.
    Hazarika M; Wangkheimayum J; Nath K; Singha KM; Chanda DD; Bhattacharjee A
    Indian J Med Microbiol; 2024; 48():100563. PubMed ID: 38518847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis and validation of different assays for glycopeptide susceptibility among methicillin-resistant Staphylococcus aureus strains.
    Bernard L; Vaudaux P; Rohner P; Huggler E; Armanet M; Pittet D; Lew DP; Schrenzel J
    J Microbiol Methods; 2004 May; 57(2):231-9. PubMed ID: 15063063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical isolates of Staphylococcus aureus from 1987 and 1989 demonstrating heterogeneous resistance to vancomycin and teicoplanin.
    Rybak MJ; Cha R; Cheung CM; Meka VG; Kaatz GW
    Diagn Microbiol Infect Dis; 2005 Feb; 51(2):119-25. PubMed ID: 15698717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.